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Abbreviation list 
 
aSAH: aneurysmal subarachnoid hemorrhage 
AUC: area under the curve 
CBF: cerebral blood flow 
CBV: cerebral blood volume 
CI: confidence interval 
CTP: CT perfusion 
DCI: delayed cerebral ischemia 
HU: Hounsfield units 
MCA: middle cerebral artery 
MTT: mean transit time 
ROC: receiver operator characteristics 
ROI: region of interest 
SD: standard deviation 
SVD: standard algorithm program 
TTD: time to drain 
TTP: time to peak 
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Abstract 
Background: Delayed cerebral infarction after aneurysmal subarachnoid hemorrhage (aSAH) 
still remains the leading cause of disability in patients that survive the initial ictus. It has been 
shown that CT perfusion (CTP) imaging can detect hypoperfused brain areas. The aim of this 
study was to evaluate if a single acute CTP examination at time of neurological deterioration 
is sufficient or if an additional baseline CTP increases diagnostic accuracy.  
Methods: Retrospective analysis of acute and baseline (within 24 hours after aneurysm 
treatment) CTP examinations of patients with neurological deterioration because of 
vasospasm-related hypoperfusion. Patients without clinical deterioration during the 
vasospasm period served as controls. The following CTP parameters were analyzed for 
predefined brain regions: time to drain (TTD), mean transit time, time to peak, cerebral blood 
flow and volume.  
Results: 33 patients with and 23 without neurological deterioration were included. Baseline 
CTP examination did not ameliorate diagnostic accuracy of the acute CTP examination in 
symptomatic patients. The same was true for inter-hemispheric comparison of perfusion 
parameters of the acute examination. The CTP parameter with the highest diagnostic yield 
was TTD of the symptomatic brain region (threshold value 4.7 sec, sensitivities 97 %, 
specificities 96 %).   
Conclusions: Acute CTP examination in case of suspected vasospasm-induced neurological 
deterioration after aSAH has the highest diagnostic accuracy to detect misery perfusion. 
Additional baseline CTP is not needed. The most sensitive parameter to detect critically 
perfused brain areas is TTD.  
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Introduction 
In aneurysmal subarachnoid hemorrhage (aSAH) cerebral vasospasm remains the leading 
cause of disability in patients that survive the initial ictus and in whom the ruptured aneurysm 
has been secured 1-3. The reported incidence of vasospasm-induced cerebral infarction is up to 
44% 4-6. For guidance of therapy, early diagnosis of evolving cerebral vasospasm and misery 
perfusion as well as exclusion of other possible causes for clinical deterioration are therefore 
crucial.  In the past, various diagnostic methods for detection of cerebral vasospasms have 
been evaluated 7-16. Because of its diagnostic accuracy and clinical applicability, computed 
tomography perfusion (CTP) imaging is more and more used in clinical practice. Reported 
sensitivities for detection of delayed cerebral ischemia (DCI) range from 20% to 95% with 
specificities higher than 66% 8, 9, 17, 18. The diagnostic accuracy strongly depends on the 
perfusion parameter being used for analysis. Several studies have shown that mean transit 
time (MTT) and time to peak (TTP) show superior sensitivities and specificities than the 
parameters cerebral blood flow (CBF) and cerebral blood volume (CBV) 19-23. A recent study 
confirmed these earlier findings and elaborated that the relatively new parameter TTD is even 
more effective to detect DCI 24. TTD is defined as time to start + MTT and measures the time 
the contrast agent passes away from the analyzed voxel. Several studies evaluated threshold 
values for the above CTP parameters by either comparing hemispheric difference or absolute 
values of hypoperfused brain areas and reported no clear benefit of either method 19, 22. The 
aim of this study was to evaluate if a single CTP at the time of neurological deterioration is 
sufficient or if serial CTP examinations are needed to reliably detect brain areas at risk for 
infarction and which CTP parameter is most appropriate.  
 
Materials and Methods 
This is a single-center retrospective case-control study of patients with aSAH treated at the 
University Hospital Bern, Switzerland. The institutional review board of the University 
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Hospital Bern and the local ethics committee (Kantonale Ethikkommission Bern, 
Switzerland) gave approval for the access and use of the data collective with the intention for 
retrospective clinical research. Only patients aged >18 years and < 80 years were included.  
 
Design 
We retrospectively searched our prospectively conducted database for patients with aSAH 
admitted between January 2012 and December 2015. Clinical courses of all patients were 
evaluated carefully and patients with neurological deterioration due to cerebral vasospasms 
and patients with clinically stable course were extracted. Patients with deterioration caused by 
other pathologies such as hydrocephalus, infection, intracerebral bleeding, metabolic 
disturbances or epileptic seizures were excluded from the analysis. DCI was defined as acute 
occurring neurological deficit fulfilling the following criteria: decrease of Glasgow Coma 
Scale of at least 2 points and/or increase of the National Institutes of Health Stroke Scale 
(NIHSS) of at least 2 points. Out of this selection, only patients with CTP examination within 
24 hours after aneurysm treatment (baseline CTP) and follow up CTP examination at time of 
acute neurological deterioration were included (acute CTP). Patients with clinically stable 
course, which underwent CTP examination within 24 hours after aneurysm treatment 
(baseline CTP) and follow up CTP examination during the vasospasm phase (day 5 to 14 after 
aSAH) served as controls. According to our treatment algorithm in patients with aSAH an 
early CTP examination is performed within 24 hours after aneurysm treatment for diagnosis 
of treatment associated abnormalities. During the follow-up period, additional CTP is 
performed in case of acute occurring neurological deficit or if indicated for other reasons by 
the treating physician.  
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 Vulcu 
 
Imaging Protocol and data processing 
CTP was performed using a 128-slice scanner (Somatom Definition Edge, Siemens 
Healthcare, Erlangen, Germany). In routine practice, our institute’s perfusion images are 
planned in a supra-orbitomeatal vertical line. The perfusion images were obtained during 
application of 30 ml of intravenous contrast medium (Iomeron 400, Bracco Suisse SA, Manno 
TI, Switzerland) followed by a 30ml saline flush with 5 ml/s flow with a mechanical injector 
(Swiss Medical Care, Lausanne, Switzerland). The acquisition parameters of the CTP were: 
slice thickness 5.0 mm; matrix 512 × 512; FOV 20; total acquisition time 57 s by tube 
current-time product of 200 mAs; and tube voltage 80 kv. CTP resulted on average in a CTDI 
of 223 mGy and on average a dose-length product of 2630 mGy.cm. Automatic exposure 
control was not applied as it could affect the perfusion parameter 25, 26. 
Quantitative analysis was done using a standard algorithm (SVD) program (syngo.via, 
Siemens Healthcare GmbH, Erlangen, Germany). Ten standard regions-of-interest (ROIs) 
were set on two rostro-caudal levels of the acquired CTP:  a) centrum semiovale (Figure 1a) 
and b) 3rd ventricle (Figure 1b). At the level of the centrum semiovale 2 ROIs were 
symmetrically set in the vascular territory of the middle cerebral artery (MCA) (Figure 1a). At 
the level of the 3rd ventricle 6 ROIs were symmetrically placed in the vascular territory of the 
anterior cerebral artery, the MCA and the posterior cerebral artery (Figure 1b). Additionally, 2 
ROIs were placed in the region of the basal ganglia (Figure 1c). For each marked ROI the 
parameters: MTT, TTP, TTD, CBF and CBV were automatically generated by the scanner 
software program (commercial perfusion package VPCT-Neuro, Siemens Healthcare, 
Forchheim, Germany). The recently into the software implemented parameter TTD describes 
the time of contrast medium washout. Specifically, TTD is defined as the sum of the delay 
between contrast medium injection and first cerebral arterial enhancement (also called “time 
to start”) and MTT. The utilized deconvolution method and the calculation of the perfusion 
maps have been described in detail by Abels et al. 27. Motion correction and 4D noise 
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reduction options were applied as provided by the perfusion software. Hounsfield Units (HU)-
based semi-automatic segmentation of the brain tissue was performed. Arterial input function 
was measured in the MCA; the venous outflow was taken from the superior sagittal sinus. 
Evaluation of perfusion map images was performed by one experienced neuroradiologist 
(WF), who was blinded to the clinical course of the examined patients. 
 
Statistical Analysis 
Statistical analyses were performed using SPSS Statistics 21.0 (IBM, Armonk, NW, USA). 
The Shapiro-Wilk normality test was used to test for normal distribution of data sets. The 
unpaired t-test was applied to test for significant differences of metric variables between the 
two groups. For comparison of CTP variables (MTT, TTP, TTD, CBV and CBF) in patients 
with DCI, the ROI corresponding to the clinically symptomatic brain area was defined. The 
same ROI was selected in the baseline CTP.  In the clinically unaffected hemisphere the 
corresponding mirror ROI was selected from the baseline and acute CTPs. In patients without 
DCI, the ROI placed in the vascular territory of the left MCA at the level of the centrum 
semiovale was analyzed and compared to the mirror ROI of the right hemisphere and the 
corresponding ROIs of the baseline CTP respectively.  Multivariate ANOVA for repeat 
measures was used to test for differences in perfusion parameters. Data are presented as mean 
± standard deviation (SD). A p-value < 0.05 was considered statistically significant. 
The diagnostic threshold values for the distinct perfusion parameters (absolute and for 
hemispheric differences at the time point of DCI as well as compared to the baseline CTP) 
were determined using receiver operator characteristics (ROC) curves. From the ROC curves, 
optimal threshold values to distinguish between patients with and without DCI were derived 
by seeking the best tradeoff between highest possible sensitivities and specificities. 
Determined sensitivities and specificities were then used to create likelihood ratio graphs to 
visualize diagnostic properties of the different CTP parameters. 
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Results 
Patients’ clinical characteristics 
One hundred sixty-five patients were evaluated for this study, of which 109 were excluded 
because they did not match the inclusion criteria or because of incomplete clinical data sets 
and/or incomplete/insufficient radiological data. Finally, 33 patients with DCI and 23 patients 
without DCI (control group) were enrolled. Table 1 shows clinical characteristic of patients 
with DCI and the control group. There was a tendency for a higher percentage of female 
gender and a higher WFNS and BNI score in the DCI group.  
 
CT Perfusion parameters 
Figure 2 a-c and Figure 3 a-b show MTT, TTP, TTD, CBF and CBV for both hemispheres of 
baseline and acute CTP examinations for patients with DCI and controls. In patients with 
DCI, MTT, TTP and TTD were significantly prolonged and CBF decreased compared to the 
not symptomatic hemisphere and to the baseline CTP. The changes of MTT, TTP and TTD 
were more prominent than the change of CBF. The unaffected hemisphere showed no changes 
of perfusion characteristics in the acute CTP compared to the baseline CTP both in patients 
with DCI and in controls.  
 
Threshold values for predicting DCI 
Table 2 shows diagnostic threshold values for distinct CTP parameters derived from the ROC 
analysis. Separate threshold values were calculated for the symptomatic hemisphere as well as 
the inter-hemispheric difference in the acute CTP and for the difference between the acute and 
baseline CTP investigations. The corresponding likelihood ratio graphs are shown in Figure 4 
a-d. Overall, the CTP parameter with the highest sensitivity and specificity was absolute TTD 
of the symptomatic brain area in the acute CTP. The threshold value was 4.7 sec. Comparison 
with the contralateral side in the acute CTP or the same region in the baseline examination 
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resulted in slightly lower sensitivities and specificities. The other parameters with good 
diagnostic properties were TTP and MTT. Whereas MTT showed similar area under the curve 
(AUC) values (confidence interval (CI) 95%) for the symptomatic side as well as the inter-
hemispheric comparison in the acute CTP, TTP showed a slightly better diagnostic accuracy 
for inter-hemispheric differences than for the symptomatic side only in the acute CTP.  
 
 
Discussion 
In aSAH vasospasm-induced cerebral infarction still remains the leading cause of disability in 
patients that survive the initial ictus 1-3. In our retrospective study we analyzed if a single CTP 
at time of neurological deterioration is sufficient to reliably detect critically hypoperfused 
brain areas or if an additional baseline CTP examination increases the diagnostic yield. In 
addition, the CTP parameters with the highest specificity and sensitivity were determined. 
Overall, additional baseline CTP examination did not ameliorate diagnostic accuracy of the 
acute CTP examination in symptomatic patients. The same was true for inter-hemispheric 
comparison of perfusion parameters of the acute examination. The CTP parameter with the 
highest diagnostic yield was TTD, followed by TTP and MTT.   
Changes of systemic hemodynamic parameters in patients after aSAH in parallel to evolving 
cerebral vasospasms are a well-known phenomenon 28, 29. Typically, an increase of systemic 
blood pressure can be observed, which is more pronounced in patients with more severe 
cerebral vasospasms 28. Based on this phenomenon, one may expect systematic alterations of 
CTP examinations acquired in patients with vasospasms, e.g. global changes of CTP 
parameters involving also non-symptomatic brain areas. We therefore compared CTP 
examinations of patients with and without acute neurological deficit with a baseline CTP 
examination acquired before the onset of the vasospasm period. In patients with acute 
neurological deficit, there were no changes of CTP parameters in clinically asymptomatic 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 Vulcu 
 
brain areas between the baseline and the acute CTP examination found (Figure 2 a-c, Figure 3 
a-b). The same was true for clinically asymptomatic patients. Hence, systemic alterations of 
hemodynamic parameters seem not to affect CTP examinations. This may be explained by 
two reasons. First, for CTP analysis arterial input function has to be determined. Generally, a 
basal cerebral artery (e.g. MCA) is selected for this purpose, which minimizes effects of 
systemic hemodynamics on measured CTP parameters. Second, cerebral autoregulation, if not 
impaired, maintains cerebral blood flow constant and may compensates for changes in 
systemic hemodynamics. Hence, a baseline CTP does not improve the diagnostic yield and is 
therefore not required. For clinical practice, this leads to a reduction of the number of 
transportations of critically ill patients from the intensive care unit to the neuroradiology 
department with possible harm of the patient during transportation, exposure of the patient to 
radiation and high costs 30, 31. 
Of all evaluated CTP parameters, TTD was found to have the best diagnostic accuracy for 
detecting critical hypoperfusion in patients with acute neurological deficits (Table 2). TTD is 
a recently introduced deconvolution-based parameter describing the time of contrast medium 
washout. It is defined as the sum of the time from arterial enhancement to tissue enhancement 
(time to start) and MTT, being sensitive to hemodynamic disturbances. In our study, three 
conditions were analyzed: i) acute CTP - clinically symptomatic brain area, ii) acute CTP - 
inter-hemispheric difference and iii) difference between acute and baseline CTP examination. 
TDD showed for all three conditions excellent diagnostic accuracies (AUC 0.951 – 0.992). 
Highest diagnostic accuracy was found for absolute values of the clinically symptomatic brain 
area in the acute CTP (AUC 0.992, threshold value 4.7 sec, sensitivities 97 %, specificities 96 
%; Table 2). This is well in line with a recent report from Othman et al.24, which correlated 
volume perfusion CT maps with findings of cerebral angiography and found superior 
diagnostic accuracy for TTD compared to MTT, CBV and CBF. Since that study did not 
include patients with acute neurological deficit, no threshold values for TTD were derived. 
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The other CTP parameters with good diagnostic accuracy were TTP and MTT. As for TTD, 
diagnostic accuracy was highest in the acute CTP examination for both parameters (Table 2). 
Comparison with the baseline CTP examination resulted in a lower diagnostic yield. In the 
acute CTP, MTT showed similar AUC values for the symptomatic brain region and for the 
inter-hemispheric comparison. TTP showed a slightly higher diagnostic accuracy for inter-
hemispheric differences than for the symptomatic side only (Table 2). Earlier studies already 
showed high sensitivities and specificities for MTT and TTP for detecting misery perfusion in 
symptomatic patients 19, 22, 32, 33. These studies did not yet evaluate the relatively new 
parameter TTD. Because of methodological and technical difference published threshold 
values for MTT and especially for TTP vary between studies 19, 22, 32, 33.  
The findings of our study may help to facilitate diagnosis of DCI in neurologically not 
evaluable patients. This patient cohort poses one of the greatest challenges in clinical practice 
since most of the available monitoring tools are of limited value and may can miss misery 
perfusion. 
The major limitation of this study is its retrospective design in a single center setting. 
Furthermore, only a relatively small cohort of patients was finally investigated and there were 
slight differences in characteristics between the group of patients with DCI and controls. The 
latter is a frequently encountered problem in studies about vasospasms after aSAB and 
reflects the different risk profile of these patient groups. To minimize bias, perfusion map 
images were analyzed by one experienced neuroradiologist, who was blinded to the clinical 
course of the examined patients. 
 
In conclusion, our results show that acute CTP examination in case of vasospasm-induced 
neurological deterioration after aSAH has the highest diagnostic accuracy to detect misery 
perfusion and that baseline CTP is not needed. The most sensitive parameter to detect 
critically perfused brain areas during the vasospasm phase after aSAH is TTD.  
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Tables: 
 
Table 1. Patient characteristics 
Table 2. AUCs with corresponding 95% Cls of optimal CTP threshold values, as well as 
sensitivities and specificities of the different perfusion maps for the detection of cerebral 
vasospasm 
 
Figure legends: 
Figure 1: Ten ROIs were manually set on two rostro-caudal levels of the acquired CTP:  A) 
centrum semiovale and B) 3rd ventricle. 
 
Figure 2: CTP parameters of baseline and acute examinations of patients with DCI and 
controls: a) shows MTT, b) TTP, c) TTD. In patients with DCI, the ROI corresponding to the 
clinically symptomatic brain area was analyzed (bright grey). The same ROI was selected in 
the baseline CTP (white).  In the clinically unaffected hemisphere the corresponding mirror 
ROI was selected from the baseline (grey) and acute CTPs (dark grey). In patients without 
DCI, the ROI placed in the vascular territory of the left MCA at the level of the centrum 
semiovale was analyzed (bright grey) and compared to the mirror ROI of the right hemisphere 
(dark grey) and the corresponding ROIs of the baseline CTP respectively (white and grey 
columns). Columns and whiskers show mean ± SEM; asterisks indicate significant differences 
by multivariate ANOVA for repeat measures, * = P <  0.05, *** = P <  0.001 
 
Figure 3: CTP parameters of baseline and acute examinations of patients with DCI and 
controls: a) CBF and b) CBV. In patients with DCI, the ROI corresponding to the clinically 
symptomatic brain area was analyzed (bright grey). The same ROI was selected in the 
baseline CTP (white).  In the clinically unaffected hemisphere the corresponding mirror ROI 
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was selected from the baseline (grey) and acute CTPs (dark grey). In patients without DCI, 
the ROI placed in the vascular territory of the left MCA at the level of the centrum semiovale 
was analyzed (bright grey) and compared to the mirror ROI of the right hemisphere (dark 
grey) and the corresponding ROIs of the baseline CTP respectively (white and grey columns). 
Columns and whiskers show mean ± SEM; asterisks indicate significant differences by 
multivariate ANOVA for repeat measures, * = P <  0.05, *** = P <  0.001 
 
Figure 4: Likelihood ratio graphs derived from ROC curves for optimal threshold values: a) 
acute versus baseline CTP, b) acute CTP symptomatic hemisphere only and c) acute CTP 
hemispheric comparison. d) Diagnostic test qualities. The four regions correlate with overall 
superiority or overall inferiority of the analyzed modality and their power to show presence or 
absence of disease.  
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 1. Patient characteristics  
 
DCI No DCI P-value 
unpaired t-Test 
No. of patients 33 23  
No. of men 
  6 (18%) 10 (43%)  
Median age (range) 53 (36-72) 55 (22-80) 0.429 
Admission WFNS score    
1 
  7 (21%) 10 (43%)  
2 
  9 (27%)   3 (13%)  
3 
  4 (12%)   3 (13%)  
4 
  5 (15%)   3 (13%)  
5 
  8 (24%)   4 (17%)  
BNI score 
   
1 
  0 (0%)   0 (0%)  
2 
  3 (9%)   5 (22%)  
3 15 (45%) 10 (43%)  
4 
  6 (18%)   6 (26%)  
5 
  9 (27%)   2 (9%)  
Fisher score 
   
1 
  0 (0%)   0 (0%)  
2 
  1 (3%)   3 (13%)  
3 28 (85%) 18 (78%)  
4 
  4 (12%)   2 (9%)  
Hunt & Hess score  
   
1 
  4 (12%)   8 (35%)  
2 11 (33%)   6 (26%)  
3 
  7 (21%)   3 (13%)  
4 
  6 (18%)   4 (17%)  
5 
  5 (15%)   2 (9%)  
ICB 12 (36%)    7 (30%)  
Aneurysm location    
ICA 
  2 (6%)   2 (9%)  
MCA 
  6 (18%)   2 (9%)  
ACOM 10 (30%) 10 (43%)  
ACA 
  0 (0%)   1 (4%)  
VA 
  2 (6%)   0 (0%)  
PICA 
  1 (3%)   2 (9%)  
SCA 
  1 (3%)   0 (0%)  
Basilar 
  2 (6%)   0 (0%)  
A. pericallosa (A2) 
  1 (3%)   3 (13%)  
PICOM 
  8 (24%)   3 (13%)  
Aneurysm treatment 
   
Coiling 24 (73%) 21 (91%)  
Clipping 
  9 (27%)   2 (9%)  
Median Day of follow up CT after SAH  (range) 9 (5-22) 8 (3-13) 0.996 
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Table 2. AUCs with corresponding 95% Cls of optimal CTP threshold values, as well as sensitivities and specificities of 
the different perfusion maps for the detection of cerebral vasospasm 
Perfusion map AUC (95% Cl) Threshold Sensitivity Specificity  
Absolute values follow-up CTP, symptomatic territory     
MTT (sec) 0.955 (0.909-1.000)   4.15  0.91  0.87 
TTP (sec) 0.935 (0.860-1.000) 10.16  0.94  0.87 
TTD (sec) 0.992 (0.977-1.000)   4.70  0.97  0.96 
cBV (mL/100 g) 0.051 (0.001-0.102)   3.20  0.33  0.13 
cBF (mL/100g/min) 0.133 (0.036-0.230) 49.29  0.21  0.13 
 
Interhemispheric comparison follow-up CTP     
MTT difference (sec) 0.955 (0.909-1.000)    0.98  0.67  1.00 
TTP difference (sec) 0.996 (0.987-1.000)    0.92  0.91  1.00 
TTD difference (sec) 0.992 (0.977-1.000)    0.63  0.97  0.91 
cBV ratio (sec) 0.610 (0.463-0.757)    0.96  0.64  0.57 
cBF ratio (sec) 0.831 (0.726-0.937)    1.01  0.88  0.65 
 
Comparison follow-up versus baseline CTP     
MTT difference (sec) 0.854 (0.744-0.964)   0.94  0.67  0.96 
TTP difference (sec) 0.792 (0.672-0.911)   0.91  0.82  0.65 
TTD difference (sec) 0.951 (0.899-1.000)   0.59  0.91  0.87 
cBV ratio (sec) 0.656 (0.504-0.808)   1.07  0.67  0.61 
cBF ratio (sec) 0.826 (0.720-0.932)   1.04  0.85  0.61 
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Figure 4
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Highlights: 
 
• Acute CTP in acute neurological deteriotation due to vasospasm has the highest 
diagnostic accuracy 
• There are no repetitive CTP examinations mandatory 
• TTD is the most sensitive parameter to detect critically perfused brain areas 
• MTT and TTP are also good reliable parameters to show hypoperfusion 
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